Imexpharm Corp (IMP) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.044x

Based on the latest financial reports, Imexpharm Corp (IMP) has a cash flow conversion efficiency ratio of 0.044x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫103.49 Billion ≈ $3.93 Million USD) by net assets (₫2.38 Trillion ≈ $90.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Imexpharm Corp (IMP) liquidity interval to measure how many days the company can operate on defensive assets alone.

Imexpharm Corp - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Imexpharm Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Imexpharm Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imexpharm Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Repco Home Finance Limited NSE:REPCOHOME	-0.095x
What's Cooking Group NV/SA BR:WHATS	0.010x
Fidelity D&D Bancorp Inc NASDAQ:FDBC	0.031x
Fresnillo PLC LSE:FRES	0.247x
Daelim Paper Co.Ltd KQ:017650	0.018x
2Seventy Bio Inc NASDAQ:TSVT	-0.051x
Transcontinental Inc TO:TCL-A	-0.095x
Ressources Minieres Radisson Inc V:RDS	-0.022x

Annual Cash Flow Conversion Efficiency for Imexpharm Corp (2019–2025)

The table below shows the annual cash flow conversion efficiency of Imexpharm Corp from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Imexpharm Corp.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₫2.31 Trillion ≈ $87.63 Million	₫54.17 Billion ≈ $2.06 Million	0.023x	-76.29%
2024-12-31	₫2.18 Trillion ≈ $82.95 Million	₫216.27 Billion ≈ $8.22 Million	0.099x	+610.25%
2023-12-31	₫2.08 Trillion ≈ $79.20 Million	₫-40.47 Billion ≈ $-1.54 Million	-0.019x	-109.71%
2022-12-31	₫1.89 Trillion ≈ $71.98 Million	₫378.60 Billion ≈ $14.38 Million	0.200x	+52.68%
2021-12-31	₫1.79 Trillion ≈ $68.18 Million	₫234.88 Billion ≈ $8.92 Million	0.131x	+209.64%
2020-12-31	₫1.73 Trillion ≈ $65.75 Million	₫73.15 Billion ≈ $2.78 Million	0.042x	-1.04%
2019-12-31	₫1.56 Trillion ≈ $59.23 Million	₫66.59 Billion ≈ $2.53 Million	0.043x	--

About Imexpharm Corp

VN:IMP Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$266.24 Million

₫7.01 Trillion VND

Market Cap Rank

#15473 Global

#86 in Vietnam

Share Price

₫45500.00

Change (1 day)

-0.22%

52-Week Range

₫45300.00 - ₫56700.00

All Time High

₫97000.00